ACADIA Pharmaceuticals Inc. (ACAD) financial statements (2020 and earlier)

Company profile

Business Address 3611 VALLEY CENTRE DRIVE
SAN DIEGO, CA 92130
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments684474341529215322186
Cash and cash equivalents385135691641026212
Short-term investments298339272365113261174
Receivables32281872  
Inventory, net of allowances, customer advances and progress billings5454  
Inventory5454   
Prepaid expense21218    
Other undisclosed current assets   8223
Total current assets:742526373548219325188
Noncurrent Assets
Operating lease, right-of-use asset10
Property, plant and equipment3333211
Intangible assets, net (including goodwill)3467  
Intangible assets, net (excluding goodwill)3467   
Restricted cash and investments55     
Other noncurrent assets2201000
Other undisclosed noncurrent assets  220  
Total noncurrent assets:23141113311
TOTAL ASSETS:766540385561222325189
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities6860494022209
Accounts payable3394220
Accrued liabilities6456403620147
Employee-related liabilities     42
Deferred revenue and credits 3  0
Other undisclosed current liabilities     (4)(2)
Total current liabilities:6860494322167
Noncurrent Liabilities
Long-term debt and lease obligation6      
Operating lease, liability6
Liabilities, other than long-term debt2      
Other liabilities2      
Other undisclosed noncurrent liabilities 200000
Total noncurrent liabilities:9200000
Total liabilities:7661494322167
Stockholders' equity
Stockholders' equity attributable to parent689479335518200309182
Common stock0000000
Additional paid in capital2,3401,9481,5591,452862808588
Accumulated other comprehensive income (loss)0(0)(0)00(0)0
Accumulated deficit(1,651)(1,469)(1,224)(934)(663)(498)(406)
Total stockholders' equity:689479335518200309182
TOTAL LIABILITIES AND EQUITY:766540385561222325189

Income statement (P&L) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues30022412517001
Revenue, net12517   
Cost of revenue(19)(18)(14)(4)(3)  
Cost of goods and services sold(1)(3)(14)(4)(3)  
Other undisclosed gross profit6651   
Gross profit:28821111614(2)01
Operating expenses(539)(453)(404)(286)(165)(93)(39)
Other undisclosed operating income (loss)(6)(6)(4)(1)3  
Operating loss:(257)(247)(292)(273)(165)(93)(38)
Nonoperating expense(1)(4)     
Investment income, nonoperating(2)(2)     
Other nonoperating income (expense)1(2)     
Other undisclosed income from continuing operations before equity method investments, income taxes77430  
Loss from continuing operations before equity method investments, income taxes:(251)(244)(288)(270)(164)(93)(38)
Other undisclosed income from continuing operations before income taxes4      
Loss from continuing operations before income taxes:(247)(244)(288)(270)(164)(93)(38)
Income tax expense(0)(1)(1)(1)(0)  
Net loss:(248)(245)(289)(271)(164)(93)(38)
Other undisclosed net income attributable to parent     10
Net loss available to common stockholders, diluted:(248)(245)(289)(271)(164)(92)(38)

Comprehensive Income ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net loss:(248)(245)(289)(271)(164)(93)(38)
Other comprehensive income (loss) 0(1)00(0)0
Other undisclosed comprehensive income0      
Comprehensive loss:(248)(245)(290)(271)(164)(93)(38)
Other undisclosed comprehensive income, net of tax, attributable to parent1    10
Comprehensive loss, net of tax, attributable to parent:(247)(245)(290)(271)(164)(93)(38)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: